Dr. Dinora Beatriz Chinchilla, MD

Dr. Chinchilla practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Chinchilla's NPI, 1508276197, was assigned on May 5, 2014. Dr. Chinchilla graduated from UC Irvine School of Medicine in 2014. Dr. Chinchilla holds California license A139407.

Dr. Chinchilla's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Chinchilla's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Chinchilla is also affiliated with Providence St. Joseph Hospital Orange. The medical group on file is UCI Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chinchilla practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Chinchilla's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Chinchilla is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Chinchilla is licensed in California.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pulmonary heart disease and tobacco use among the conditions Dr. Chinchilla treats.

CMS data shows 811 Medicare services from Dr. Chinchilla across 16 procedure codes in 2024, for 371 Medicare patients. Medicare paid $89,344 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 371 Medicare patients who saw Dr. Chinchilla in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 2.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chinchilla's median patient age at 63, with 52% women.

In 2024, Dr. Chinchilla wrote 376 Medicare Part D claims for 67 patients. 33% of them were for generic drugs. CMS names the drug for 277 of them, across 11 drugs with 11 or more claims each, at $100,773 in total drug cost. In 2023, CMS named 167 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chinchilla for performance year 2024, reported through an alternative payment model (APM). Dr. Chinchilla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chinchilla as offering telehealth.

Dmand AI links 3 papers to Dr. Chinchilla in 2024. Dr. Chinchilla's most frequent co-authors are Nadine Abi-Jaoudeh, MD, Kenneth Huynh and Gelareh Sadigh, MD.

CMS Open Payments shows 53 general payments to Dr. Chinchilla from 12 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 94% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $402.

Dr. Chinchilla graduated from UC Irvine School of Medicine in 2014.

Dr. Chinchilla is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.